lereca glp-1 Medications for Weight Loss The GLP-1 Revolution: The Science,

doi: 10.1111/ppl.13543 100 FoyerC

Schedule an Appointment to Learn More If youre interested in learning more about how GLP-1/GIP receptor agonists can help you achieve your weight loss and health goals, schedule an appointment with Boise Natural Health Clinic today

Food and Drug Administration (FDA) approved Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related condition, such as high blood pressure or type 2 diabetes

In the US, Wegovy is approved for use in individuals with a BMI over 30 with no other co-morbidities and 27 in individuals with a weight-related condition, such as hypertension